Analysts expect ZyVersa Therapeutics, Inc. to report revenue of 0.00 for Q3 24, against a range of 0.00 to 0.00. The most recent reported quarter, Q1 26, came in at -132,512.00.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | - | - | - | -130,036.00 | -131,350.00 | -132,263.00 | -132,512.00 | - | - | - | - | - | ||||||||||
| High Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Low Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Consensus Estimate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Analysts expect ZyVersa Therapeutics, Inc. to report earnings per share of -15.22 for Q2 26, against a range of -15.97 to -14.47. The most recent reported quarter, Q1 26, came in at -0.22, a 98.5% beat against the -15.27 consensus.
| Metric | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -4.53 | -3.31 | -2.43 | 1.79 | -0.73 | -0.46 | -2.56 | -0.43 | -0.22 | - | - | - | - | - | - | - | - | |||||||
| High Estimate | -3.30 | -1.87 | -1.59 | -2.65 | -0.40 | -0.39 | -0.25 | -0.29 | -14.14 | -14.47 | -16.92 | -15.49 | -20.02 | -18.56 | -22.17 | -22.54 | -26.35 | |||||||
| Low Estimate | -3.72 | -2.29 | -1.81 | -3.07 | -0.44 | -0.45 | -0.27 | -0.33 | -16.40 | -15.97 | -19.32 | -17.89 | -23.10 | -21.68 | -23.75 | -25.60 | -31.79 | |||||||
| Consensus Estimate | -3.51 | -2.08 | -1.70 | -2.86 | -0.42 | -0.42 | -0.26 | -0.31 | -15.27 | -15.22 | -18.12 | -16.69 | -21.56 | -20.12 | -22.96 | -24.07 | -29.07 |
Pull Wall Street consensus for ZyVersa Therapeutics, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ZVSA&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ZVSA", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ZVSA&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();